News

• A Long and Winding Road: Surviving the Shock of Malpractice Litigation
  

  Robert Widi, VP Sales  This is my twentieth year working in sales for OMIC and I’m still surprised every time I encounter an ophthalmologist who is focused solely on price when choosing a carrier to represent them when a malpractice claim is ultimately filed against their practice. I say “when” a claim is filed, not […]

• Notes from Boston: OMIC at the 2014 ASCRS/ASOA Meeting
  

  Thanks to the more than 200 people who’ve already stopped by to see us at the OMIC Exhibit, Booth 163, at the 2014 ASCRS/ASOA Meeting in Boston! See the ASCRS/ASOA Page for more information and updates from the meeting. Stop by the OMIC Booth for: Information on 2014 Dividend Service and Coverage Changes Phone Call […]

• FDA Recall Alert: Hospira Announces Voluntary Recall of One Lot of 0.25 Percent Marcaine, Bupivacaine HCI Injection, USP, Due to Visible Particulates
  

  From ASCRS/ASOA Bulletin: The Food and Drug Administration (FDA) alerted providers that Hospira, Inc. is conducting a nationwide recall of one lot of 0.25% Marcaine, Bupivacaine HCI Injection, USP, 10ml, single-dose vial, preservative-free to the user level due to a confirmed customer report of discolored solution with visible particles embedded in the glass as well […]

• WSJ Opinion: California’s MICRA Should Be Protected
  

  This week, the Wall Street Journal editors looked at California’s MPL award cap. The opinion piece stated that MICRA is “… the gold standard in medical malpractice reform, (and) has inspired legislation in more than a dozen states, most notably Texas.” According to the editors, attorneys unsuccessfully sued to overturn California’s cap in 1985 and […]